跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial
Approved
STANDARD
SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial
Apellis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b4ac763b82bac467
Company
Apellis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b4ac763b82bac467
Product Name
SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial
Artg Id
404733
Artg Name
SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial
Sponsor
Apellis Australia Pty Ltd
Company Detail Path
/organization/apellis-australia-pty-ltd
Artg Date
2025-01-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a9a3d964471b770f882d56c467235ce2.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/cc6a5fa55b9f1b9049e9bbbb23491e61.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b4ac763b82bac467
Type
Standard
Back to TGA Approvals